 | • レポートコード：MRC23Q35864 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の細胞生存率アッセイ＆消耗品市場について調査・分析し、世界の細胞生存率アッセイ＆消耗品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ヒト細胞、動物細胞、植物細胞）、用途別セグメント分析（製薬会社、バイオセンター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Bio-Rad Laboratories、Merck、GE Healthcare、BioTek Instruments、PerkinElmer、Promega Corporation、Biotium、Abcamplc、Canvax、Abnova、G-Biosciences、Creative Bioarray、Danaher Corporation、Becton、Dickinson and Companyなどが含まれています。 世界の細胞生存率アッセイ＆消耗品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、細胞生存率アッセイ＆消耗品市場規模を推定する際に考慮しました。本レポートは、細胞生存率アッセイ＆消耗品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、細胞生存率アッセイ＆消耗品に関するビジネス上の意思決定に役立てることを目的としています。 ・細胞生存率アッセイ＆消耗品市場の概要 - 細胞生存率アッセイ＆消耗品のタイプ別セグメント - 世界の細胞生存率アッセイ＆消耗品市場規模：タイプ別分析（ヒト細胞、動物細胞、植物細胞） - 細胞生存率アッセイ＆消耗品の用途別セグメント - 世界の細胞生存率アッセイ＆消耗品市場規模：用途別分析（製薬会社、バイオセンター、その他） - 世界の細胞生存率アッセイ＆消耗品市場規模予測（2018年-2029年） ・細胞生存率アッセイ＆消耗品市場の成長トレンド - 細胞生存率アッセイ＆消耗品の地域別市場規模（2018年-2029年） - 細胞生存率アッセイ＆消耗品市場ダイナミクス - 細胞生存率アッセイ＆消耗品の業界動向 - 細胞生存率アッセイ＆消耗品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ヒト細胞、動物細胞、植物細胞 - 世界の細胞生存率アッセイ＆消耗品のタイプ別市場規模（2018年-2023年） - 世界の細胞生存率アッセイ＆消耗品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：製薬会社、バイオセンター、その他 - 世界の細胞生存率アッセイ＆消耗品の用途別市場規模（2018年-2023年） - 世界の細胞生存率アッセイ＆消耗品の用途別市場規模（2024年-2029年） ・細胞生存率アッセイ＆消耗品の地域別市場規模 - 北米の細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - アメリカの細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - ヨーロッパの細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - アジア太平洋の細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - 中国の細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - 日本の細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - 韓国の細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - インドの細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - オーストラリアの細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - 中南米の細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） - 中東・アフリカの細胞生存率アッセイ＆消耗品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Bio-Rad Laboratories、Merck、GE Healthcare、BioTek Instruments、PerkinElmer、Promega Corporation、Biotium、Abcamplc、Canvax、Abnova、G-Biosciences、Creative Bioarray、Danaher Corporation、Becton、Dickinson and Company ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Cell Viability Assays and Consumables market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cell Viability Assays and Consumables is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cell Viability Assays and Consumables is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cell Viability Assays and Consumables in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cell Viability Assays and Consumables include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck, GE Healthcare, BioTek Instruments, PerkinElmer, Promega Corporation, Biotium and Abcamplc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell Viability Assays and Consumables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Viability Assays and Consumables.
The Cell Viability Assays and Consumables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Viability Assays and Consumables market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Viability Assays and Consumables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck
GE Healthcare
BioTek Instruments
PerkinElmer
Promega Corporation
Biotium
Abcamplc
Canvax
Abnova
G-Biosciences
Creative Bioarray
Danaher Corporation
Becton
Dickinson and Company
Segment by Type
Human Cells
Animal Cells
Plant Cells
Segment by Application
Pharmaceutical Company
Biological Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Viability Assays and Consumables companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Viability Assays and Consumables Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Human Cells
1.2.3 Animal Cells
1.2.4 Plant Cells
1.3 Market by Application
1.3.1 Global Cell Viability Assays and Consumables Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biological Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Viability Assays and Consumables Market Perspective (2018-2029)
2.2 Cell Viability Assays and Consumables Growth Trends by Region
2.2.1 Global Cell Viability Assays and Consumables Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Viability Assays and Consumables Historic Market Size by Region (2018-2023)
2.2.3 Cell Viability Assays and Consumables Forecasted Market Size by Region (2024-2029)
2.3 Cell Viability Assays and Consumables Market Dynamics
2.3.1 Cell Viability Assays and Consumables Industry Trends
2.3.2 Cell Viability Assays and Consumables Market Drivers
2.3.3 Cell Viability Assays and Consumables Market Challenges
2.3.4 Cell Viability Assays and Consumables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Viability Assays and Consumables Players by Revenue
3.1.1 Global Top Cell Viability Assays and Consumables Players by Revenue (2018-2023)
3.1.2 Global Cell Viability Assays and Consumables Revenue Market Share by Players (2018-2023)
3.2 Global Cell Viability Assays and Consumables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Viability Assays and Consumables Revenue
3.4 Global Cell Viability Assays and Consumables Market Concentration Ratio
3.4.1 Global Cell Viability Assays and Consumables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays and Consumables Revenue in 2022
3.5 Cell Viability Assays and Consumables Key Players Head office and Area Served
3.6 Key Players Cell Viability Assays and Consumables Product Solution and Service
3.7 Date of Enter into Cell Viability Assays and Consumables Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Viability Assays and Consumables Breakdown Data by Type
4.1 Global Cell Viability Assays and Consumables Historic Market Size by Type (2018-2023)
4.2 Global Cell Viability Assays and Consumables Forecasted Market Size by Type (2024-2029)
5 Cell Viability Assays and Consumables Breakdown Data by Application
5.1 Global Cell Viability Assays and Consumables Historic Market Size by Application (2018-2023)
5.2 Global Cell Viability Assays and Consumables Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Viability Assays and Consumables Market Size (2018-2029)
6.2 North America Cell Viability Assays and Consumables Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Viability Assays and Consumables Market Size by Country (2018-2023)
6.4 North America Cell Viability Assays and Consumables Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Viability Assays and Consumables Market Size (2018-2029)
7.2 Europe Cell Viability Assays and Consumables Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Viability Assays and Consumables Market Size by Country (2018-2023)
7.4 Europe Cell Viability Assays and Consumables Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Viability Assays and Consumables Market Size (2018-2029)
8.2 Asia-Pacific Cell Viability Assays and Consumables Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Viability Assays and Consumables Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Viability Assays and Consumables Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Viability Assays and Consumables Market Size (2018-2029)
9.2 Latin America Cell Viability Assays and Consumables Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Viability Assays and Consumables Market Size by Country (2018-2023)
9.4 Latin America Cell Viability Assays and Consumables Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Viability Assays and Consumables Market Size (2018-2029)
10.2 Middle East & Africa Cell Viability Assays and Consumables Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Viability Assays and Consumables Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Viability Assays and Consumables Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell Viability Assays and Consumables Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Cell Viability Assays and Consumables Introduction
11.2.4 Bio-Rad Laboratories Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Cell Viability Assays and Consumables Introduction
11.3.4 Merck Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.3.5 Merck Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Cell Viability Assays and Consumables Introduction
11.4.4 GE Healthcare Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.4.5 GE Healthcare Recent Development
11.5 BioTek Instruments
11.5.1 BioTek Instruments Company Detail
11.5.2 BioTek Instruments Business Overview
11.5.3 BioTek Instruments Cell Viability Assays and Consumables Introduction
11.5.4 BioTek Instruments Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.5.5 BioTek Instruments Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Cell Viability Assays and Consumables Introduction
11.6.4 PerkinElmer Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 Promega Corporation
11.7.1 Promega Corporation Company Detail
11.7.2 Promega Corporation Business Overview
11.7.3 Promega Corporation Cell Viability Assays and Consumables Introduction
11.7.4 Promega Corporation Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.7.5 Promega Corporation Recent Development
11.8 Biotium
11.8.1 Biotium Company Detail
11.8.2 Biotium Business Overview
11.8.3 Biotium Cell Viability Assays and Consumables Introduction
11.8.4 Biotium Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.8.5 Biotium Recent Development
11.9 Abcamplc
11.9.1 Abcamplc Company Detail
11.9.2 Abcamplc Business Overview
11.9.3 Abcamplc Cell Viability Assays and Consumables Introduction
11.9.4 Abcamplc Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.9.5 Abcamplc Recent Development
11.10 Canvax
11.10.1 Canvax Company Detail
11.10.2 Canvax Business Overview
11.10.3 Canvax Cell Viability Assays and Consumables Introduction
11.10.4 Canvax Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.10.5 Canvax Recent Development
11.11 Abnova
11.11.1 Abnova Company Detail
11.11.2 Abnova Business Overview
11.11.3 Abnova Cell Viability Assays and Consumables Introduction
11.11.4 Abnova Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.11.5 Abnova Recent Development
11.12 G-Biosciences
11.12.1 G-Biosciences Company Detail
11.12.2 G-Biosciences Business Overview
11.12.3 G-Biosciences Cell Viability Assays and Consumables Introduction
11.12.4 G-Biosciences Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.12.5 G-Biosciences Recent Development
11.13 Creative Bioarray
11.13.1 Creative Bioarray Company Detail
11.13.2 Creative Bioarray Business Overview
11.13.3 Creative Bioarray Cell Viability Assays and Consumables Introduction
11.13.4 Creative Bioarray Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.13.5 Creative Bioarray Recent Development
11.14 Danaher Corporation
11.14.1 Danaher Corporation Company Detail
11.14.2 Danaher Corporation Business Overview
11.14.3 Danaher Corporation Cell Viability Assays and Consumables Introduction
11.14.4 Danaher Corporation Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.14.5 Danaher Corporation Recent Development
11.15 Becton
11.15.1 Becton Company Detail
11.15.2 Becton Business Overview
11.15.3 Becton Cell Viability Assays and Consumables Introduction
11.15.4 Becton Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.15.5 Becton Recent Development
11.16 Dickinson and Company
11.16.1 Dickinson and Company Company Detail
11.16.2 Dickinson and Company Business Overview
11.16.3 Dickinson and Company Cell Viability Assays and Consumables Introduction
11.16.4 Dickinson and Company Revenue in Cell Viability Assays and Consumables Business (2018-2023)
11.16.5 Dickinson and Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details